Obagi Medical - Best Pharma Stocks of 2007
Company: Obagi Medical
Starting stock price: $9.85
Ending stock price: $18.33
Percent Change: 86.09%
Details: Obagi Medical Products has developed prescription-strength skin health systems focused on preventing and/or improving skin conditions including photodamage, hyperpigmentation (chloasma, melasma, freckles), acne, vulgaris and rosacea. The company went public in October 2007.
More stories about Obagi Medical
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: